Analysts Set Certara, Inc. (NASDAQ:CERT) PT at $20.06

Certara, Inc. (NASDAQ:CERTGet Free Report) has been assigned a consensus recommendation of “Hold” from the eleven research firms that are covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $20.06.

A number of research analysts have weighed in on CERT shares. Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research note on Monday, February 26th. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a research note on Wednesday, April 10th. UBS Group lifted their target price on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. JMP Securities started coverage on Certara in a research note on Thursday, April 4th. They set a “market perform” rating on the stock. Finally, Jefferies Financial Group upped their target price on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research note on Friday, March 1st.

Check Out Our Latest Stock Report on Certara

Insider Buying and Selling

In other news, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the sale, the senior vice president now directly owns 173,524 shares in the company, valued at $3,123,432. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Certara

Several institutional investors have recently added to or reduced their stakes in the business. Barclays PLC raised its position in shares of Certara by 32.4% in the third quarter. Barclays PLC now owns 54,167 shares of the company’s stock valued at $787,000 after purchasing an additional 13,250 shares during the period. Swiss National Bank lifted its position in shares of Certara by 1.1% during the third quarter. Swiss National Bank now owns 263,600 shares of the company’s stock worth $3,833,000 after acquiring an additional 2,900 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Certara by 5.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 607,030 shares of the company’s stock worth $8,826,000 after acquiring an additional 32,790 shares during the period. HighTower Advisors LLC grew its position in shares of Certara by 24.8% in the third quarter. HighTower Advisors LLC now owns 27,500 shares of the company’s stock valued at $390,000 after purchasing an additional 5,467 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC raised its stake in shares of Certara by 25.4% during the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 22,991 shares of the company’s stock valued at $334,000 after purchasing an additional 4,653 shares during the period. 73.96% of the stock is owned by hedge funds and other institutional investors.

Certara Stock Performance

Shares of Certara stock opened at $13.47 on Friday. The business has a 50-day simple moving average of $16.51 and a 200 day simple moving average of $16.98. Certara has a one year low of $11.81 and a one year high of $19.87. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.26 and a quick ratio of 3.26. The firm has a market capitalization of $2.17 billion, a price-to-earnings ratio of -34.54, a PEG ratio of 4.49 and a beta of 1.58.

Certara (NASDAQ:CERTGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The firm had revenue of $96.65 million for the quarter, compared to the consensus estimate of $94.48 million. On average, research analysts anticipate that Certara will post 0.29 earnings per share for the current fiscal year.

Certara Company Profile

(Get Free Report

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Featured Articles

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.